NEWS & EVENTS

We want to keep you up to date with developments in the IP world and let you know what we are up to at Mewburn Ellis.

 
NEWS & EVENTS

European Commission Publishes Position Paper on IP post-Brexit

12 Sep 2017

For many months now, we have known that Brexit is likely to bring changes to IP rights in Europe. That changed on 7 September with the publication of the European Commission’s position paper on IP.

AIPF Annual Meeting 2017

11 Sep 2017

Robert Watson will be at the Association of Intellectual Property Firms (AIPF) Annual Meeting 2017, which takes place from 13-15 September in San Francisco.

All Ohio Annual Institute on Intellectual Property 2017

07 Sep 2017

Andy King will be at AOAIOIP (All Ohio Annual Institute on Intellectual Property) 2017 from 11-15 September in Ohio, United States.

Estonia and Lithuania ratify UPC Agreement

06 Sep 2017

Estonia and Lithuania have ratified the UPC Agreement despite continuing uncertainty over UK and German ratifications. The reasons for the challenge in the German Constitutional Court (as reported here) have now been made public.

CIPA Manchester Regional Meeting 2017

06 Sep 2017

Sarah Brearley will be speaking at the CIPA Manchester Regional Meeting on Thursday 7 September 2017. The topic is “IP Inclusive Update and the Importance of Being a Work Place Ally”.

Aurelius and University of Cambridge win Horizon 2020 grant

04 Sep 2017

Aurelius Environmental, part of Aurelius Holdings, and Dr Vasant Kumar from the University of Cambridge’s Department of Materials Science and Metallurgy (DMSM) have won a grant worth over €1.3m to develop a novel process for recycling lead from lead batteries.

Exciting times in cellular immunotherapy

01 Sep 2017

Yesterday the US FDA issued the first ever approval for a cellular immunotherapy.

Zealand Pharma partner Boehringer Ingelheim initiates Phase 1 trials for diabetes/ obesity treatments

31 Aug 2017

Zealand Pharma A/S has announced that their strategic collaboration partner, Boehringer Ingelheim, has initiated Phase 1 studies assessing candidates for the treatment of obesity and/or diabetes.

Asian Patent Attorneys Association (APAA) 2017

29 Aug 2017

Rachel Oxley and Graeme Moore will be attending the 67th Council Meeting of the Asian Patent Attorneys Association (APAA) from 04-07 November 2017.

China Trademark Festival 2017

23 Aug 2017

Jacqueline Pang will be attending the China Trademark Festival which takes place in Guilin, China from 1st to 4th September.

Congratulations to our client Zealand Pharma A/S, now listed on NASDAQ

17 Aug 2017

After announcing its intentions last month, Zealand Pharma A/S has gone public in the US to fund clinical trials and other projects.

PATINEX 2017 (Patent Information Expo)

09 Aug 2017

Stephen Hodsdon will be speaking about IP strategies in Europe after Brexit at the Patinex 2017 conference that takes place from 7 -8 September 2017 in Seoul, Korea.

Cambridge Enterprise signs deal with Qkine Ltd to drive stem cell and regenerative medicine research

08 Aug 2017

Cambridge Enterprise, the commercialisation arm of the University of Cambridge, has licensed key technology to specialist growth factor manufacturer Qkine Ltd for Activin A production.

Mewburn recommended in Managing Intellectual Property: IP Stars 2017

03 Aug 2017

We are delighted to once again be ranked in the Managing Intellectual Property: IP Stars. It’s been an outstanding year for Mewburn, having received praise and multiple recommendations across the firm. We have been recognised for our "responsive service, high quality drafting and good working relationships with inventors".

Mewburn hosts team of future innovators for NCS The Challenge

03 Aug 2017

As part of our 150th anniversary celebrations, we decided to support the National Citizen Service (NCS) and take part as a professional partner for NCS The Challenge. This week, we welcomed a team of the 'next generation of innovators' to the Mewburn Ellis office in London.